Teck Resources reports strong Q4 earnings, advances Anglo American merger

Teck Resources reported stronger-than-expected Q4 2025 results with adjusted earnings of C$1.37 per share and revenue of approximately C$2.79 billion, driven by higher copper prices (US$5.03/lb average, US$5.67/lb at year-end) and improved by-product revenue. Its copper segment delivered C$1.1 billion gross profit before depreciation & amortization and C$747 million gross profit, while operations at Quebrada Blanca showed ramp-up progress; shareholders and the Canadian government have approved the proposed Anglo American merger, though additional regulatory clearances remain. U.S.-listed shares were slightly down (~1.4%) after the release, but the results and merger progress materially strengthen Teck's fundamentals and strategic outlook.

Analysis

Market structure: Teck and Anglo American are the immediate winners — Teck’s Q4 C$1.37/sh beat and C$1.1bn copper EBITDA show direct leverage to copper trading >$5/lb. Higher copper and by‑product receipts tighten pricing power for large, low‑cost copper assets (benefit: Teck, AAL, FCX; hurt: high‑unit‑cost producers and copper consumers like electronic OEMs). Expect CAD to strengthen on commodity strength, modest tightening in Teck/AAL credit spreads, and elevated equity implied vol around regulatory milestones.

Risk assessment: Key tail risks are a regulatory block in a major jurisdiction (EU/UK/China) or a Quebrada Blanca ramp/tailings incident causing >30% EPS shock; probability low but impact high. Near term (days) market reaction is muted (-1.4%); short term (weeks–6 months) regulators/corporate filings and LME/SHFE inventory prints will drive volatility; long term (12–36 months) integration, capex overruns and copper cycle determine value. Hidden dependencies include smelter processing charges, by‑product prices (zinc, moly) and CAD/USD FX on reported CAD profits.

Trade implications: Direct play: establish a 2–3% portfolio long in TECK (TSX:TECK.B or US:TECK) sized for 12‑month horizon targeting 20–35% upside if merger closes and copper stays >$5.00/lb; use stop-loss at −20% or unwind if 30‑day avg copper < $4.50. Merger arb: allocate 0.5–1% NAV to long TECK / short AAL (LSE:AAL) as a dispersion trade, cap exposure if regulatory clearance not received within 12 months. Options: buy 9–12 month TECK call spread (approx. buy 60/75 Jul–Dec 2026) sized <1% NAV to cap premium; finance by selling 3–6 month covered calls if comfortable.

Contrarian angles: Consensus understates regulatory and tailings risk; the small post‑print pullback suggests the market is complacent — mispricing exists in merger arb spreads and short‑dated calls. Historical mining M&A often takes 6–18 months and forces asset sales that reduce synergies; prepare for 10–20% downside to equity value if divestitures required. If copper rallies >10% from $5.67 to >$6.25/lb, TECK upside could accelerate; conversely, copper falling < $4.50 for 60 days should trigger de‑risking.

Key Decisions for Investors

• Establish a 2–3% NAV long position in Teck (TSX:TECK.B or US:TECK) on a 12‑month view; set a hard stop-loss at −20% or if 30‑day average LME copper < $4.50.
• Initiate a 0.5–1% NAV merger‑arb pair: long TECK short Anglo American (LSE:AAL) to capture spread on anticipated close within 6–12 months; unwind if regulatory approval not granted within 12 months or if spread widens >200 bps.
• Buy a capped upside options position: 9–12 month TECK call spread (approx. strikes 60/75 on US listing or equivalent on TSX), size <1% NAV; finance by selling 3–6 month covered calls to reduce cost and pick up yield.
• Reduce overweight in higher unit‑cost copper names by 2–3% (e.g., trim small caps/high cash‑cost miners) and redeploy to TECK and high‑quality copper exposure if copper > $5.25 persists for 30 days.
• Monitor three near‑term catalysts over next 90 days — (1) regulatory filings/announcements on merger, (2) LME/SHFE inventory trends weekly, (3) Quebrada Blanca production/tailings updates — and move to liquidate arb exposure if any negative regulatory indication or a 30% adverse change in production guidance occurs.